Traslational Cancer Drugs is a company that provides Oncology drug, Health care, Oncology drugs and more. Traslational Cancer Drugs is headquartered in Spain Madrid. Traslational Cancer Drugs was founded in 2005. Traslational Cancer Drugs has a total of 78 patents
A quick overview of tech portfolio with the top keywords and phrases extracted from patents of Traslational Cancer Drugs
Download
High Related Markets
Mentioned companies in the market reports of major market categories and sectors by Traslational Cancer Drugs
Sign up to view the full data
Free Trial Now
Download
Innovation Matrix
visualizing technology portfolio of hot application areas and blank areas for Traslational Cancer Drugs
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Traslational Cancer Drugs
Sign up to view the full data
Free Trial Now
Download
Traslational Cancer Drugs Frequently Asked Questions
What is Traslational Cancer Drugs's industry?
Traslational Cancer Drugs is in the industry of:Pharmaceutical and Medicine ManufacturingResearch and Development in the Physical, Engineering, and Life Sciences
What technical fields has Traslational Cancer Drugs researched?
What kind of company is Traslational Cancer Drugs?
Chosen as one of Spain’s top 5 biotech investment opportunities, TCD is focused on creating the future of Oncology by developing innovative therapies...
What is Traslational Cancer Drugs's official website?